Navigation Links
New Technique May Improve Early Cervical Cancer Treatment
Date:6/1/2009

Modified hysterectomy method could boost survival, German study shows

MONDAY, June 1 (HealthDay News) -- A new approach to performing radical hysterectomy in early-stage cervical cancer patients reduces the risk of complications, death and local tumor recurrence, a German study shows.

The technique, called total mesometrial resection (TMMR), is a modified version of traditional radical hysterectomy. But this new method employs more accurate, anatomically based resection of the cancer to prevent damage to the pelvic autonomous nervous system and to minimize surgery-related trauma, the University of Leipzig researchers report.

In their study, Dr. Michael Hockel and his colleagues assessed the effectiveness of TMMR without radiotherapy in 212 early-stage cervical cancer patients and found a recurrence-free survival rate of 94 percent and a five-year survival rate of 96 percent. The overall cancer recurrence rate was 5 percent, compared to the 28 percent rate seen in patients who undergo traditional radical hysterectomy.

The study, published online June 1 in The Lancet Oncology, also found that 63 percent of patients had no treatment-related complications, 35 percent had grade 1 complications, and 9 percent had grade 2 complications. There were no grade 3 or 4 complications reported.

The researchers wrote that "TMMR without adjuvant radiation has the potential to improve survival by 15 to 20 percent," and called for further evaluation of TMMR in multi-center controlled trials.

More information

The National Women's Health Information Center has more about cervical cancer.



-- Robert Preidt



SOURCE: The Lancet Oncology, news release, May 31, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1

Related medicine news :

1. New technique may help detect potential breast cancer spread
2. CorMatrix Cardiovascular to Present on its ECM Technology(TM) at the Annual Advanced Cardiac Techniques in Surgery (ACTS) Symposium in New York, N.Y.
3. Medical Nurse Training, Inc. Announces New Techniques to Achieve Tremendous Savings of Lives and Medical Costs of Over $200 Billion Annually
4. MRI: Imaging technique of choice to exam pregnant patients with possible appendicitis
5. New MR technique may help save women from unnecessary breast biopsies
6. New womens imaging technique allows for a more accurate diagnosis of breast cancer
7. IAEA conference to focus on new techniques in cancer treatment
8. New technique that scrambles light may lead to sharper images, wider views
9. First noninvasive technique to accurately predict mutations in human brain tumors
10. Robot improves suture proficiency more rapidly for surgeons inexperienced in laparoscopic techniques
11. Western Orthopaedics in Denver Blends Innovative Techniques to Provide a Spectrum of Shoulder Care
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Technique May Improve Early Cervical Cancer Treatment
New Technique May Improve Early Cervical Cancer Treatment
Other Medicine News:Health News:Hear Indiana Announces Talk*Walk*Run 2008 2Health News:Hear Indiana Announces Talk*Walk*Run 2008 3Health News:USDA Grants Organic Certification to Ayala's Herbal Water(TM) 2Health News:Prevention and control of childhood pneumonia: Bulletin of the World Health Organization 2Health News:Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting 2Health News:Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting 3Health News:AVEENO(R) Announces Sponsorship and Kick-Off of The Skin Cancer Foundation's 'Road to Healthy Skin Tour' Presented by AVEENO(R) and Rite Aid 2Health News:AVEENO(R) Announces Sponsorship and Kick-Off of The Skin Cancer Foundation's 'Road to Healthy Skin Tour' Presented by AVEENO(R) and Rite Aid 3Health News:CNS Response, Inc: rEEG(R) Research to be Presented at 38th National Council Conference 2Health News:CNS Response, Inc: rEEG(R) Research to be Presented at 38th National Council Conference 3
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR 28R 29 51761 1Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR 28R 29 51761 2Menopause Is More Than A Hot Flash 51759 1Menopause Is More Than A Hot Flash 51759 2Menopause Is More Than A Hot Flash 51759 3Menopause Is More Than A Hot Flash 51759 4Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit 51757 1Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit 51757 2Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit 51757 3